Skip to main content
JHX
NYSE Manufacturing

James Hardie Exceeds FY26 Adjusted EBITDA Guidance, Projects Strong FY27 Growth & Free Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Building Materials Stocks · Materials
Sentiment info
Positive
Importance info
8
Price
$18.9
Mkt Cap
$10.86B
52W Low
$16.46
52W High
$29.825
52W Position info
15% above low
Off High info
37% below high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

JHX is trading near its 52-week low of $16.46 (15% above the low).

Summary

James Hardie Industries exceeded its Adjusted EBITDA guidance for Q4 and full-year FY26 and provided an optimistic FY27 outlook with projected Adjusted EBITDA growth and increased Free Cash Flow, driven by synergy realization.


Key Events · Earnings and Guidance · JHX

  • Exceeded FY26 Adjusted EBITDA Guidance

    The company reported Q4 FY26 Adjusted EBITDA of $381 million and full-year FY26 Adjusted EBITDA of $1.27 billion, both exceeding prior guidance and expectations.

  • Strong FY27 Outlook

    James Hardie is targeting Pro Forma Adjusted EBITDA growth of 4% to 8% in FY27 and expects Free Cash Flow to exceed $500 million, an increase of over $200 million year-over-year.

  • AZEK Acquisition Synergies Ahead of Schedule

    Cost synergies from the AZEK acquisition are ahead of schedule, and commercial synergies are on track, reinforcing confidence in long-term value creation from the integration.

  • Significant Net Sales Growth

    Net Sales increased 45% year-over-year in Q4 FY26 to $1.40 billion and 25% for the full year to $4.84 billion, primarily driven by the AZEK acquisition.


Analysis · JHX · Manufacturing

James Hardie reported strong adjusted financial results for Q4 and full-year FY26, surpassing its Adjusted EBITDA guidance. The company also provided a positive outlook for FY27, projecting significant growth in Adjusted EBITDA and a substantial increase in Free Cash Flow, driven by successful integration and synergy realization from the AZEK acquisition. While GAAP net income declined due to acquisition-related expenses, the focus on adjusted metrics and future cash generation indicates a solid operational performance in a challenging market.

How filings like this one have moved

In the 30 days to Nov 9, 2026, 47.1% of the 1533 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.29%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, JHX was trading at $18.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $16.46 to $29.83. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

JHX - Latest Insights

JHX
Nov 05, 2026, 4:19 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $27.97
Real-time Price: $29.25 info
Change: +$1.28 (+5%) info
Market Cap: $16.98B info
JHX
Nov 05, 2026, 4:14 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $28.00
Real-time Price: $29.25 info
Change: +$1.25 (+4%) info
Market Cap: $16.98B info
JHX
Nov 05, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $28.66
Real-time Price: $29.25 info
Change: +$0.585 (+2%) info
Market Cap: $16.98B info
JHX
Sep 15, 2026, 8:52 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $28.14
Real-time Price: $29.25 info
Change: +$1.11 (+4%) info
Market Cap: $16.98B info
JHX
Aug 20, 2026, 4:36 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $30.34
Real-time Price: $29.25 info
Change: -$1.09 (-4%) info
Market Cap: $16.98B info